These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7142200)

  • 21. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
    Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
    J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mechanism of resistance to methotrexate. NADPH but not NADH stimulation of methotrexate binding to dihydrofolate reductase.
    Kamen BA; Whyte-Bauer W; Bertino JR
    Biochem Pharmacol; 1983 Jun; 32(12):1837-41. PubMed ID: 6882460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
    Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
    Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate analogues. 16. Importance of the side-chain amide carbonyl group as a structural determinant of biological activity.
    Rosowsky A; Forsch R
    J Med Chem; 1982 Dec; 25(12):1454-9. PubMed ID: 6818345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced forms of aminopterin and methotrexate in L1210 lymphoma.
    Makulu DR; Fölsch E
    J Natl Cancer Inst; 1977 Jul; 59(1):245-9. PubMed ID: 875056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.
    Jackson RC; Niethammer D; Hart LI
    Arch Biochem Biophys; 1977 Aug; 182(2):646-56. PubMed ID: 561567
    [No Abstract]   [Full Text] [Related]  

  • 28. Dihydrofolate reductase activity of leukemia L1210 during development of methotrexate resistance.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Biochem Pharmacol; 1971 Mar; 20(3):716-8. PubMed ID: 5150168
    [No Abstract]   [Full Text] [Related]  

  • 29. Dihydrofolate reductase activity and loss of resistance in an antifolate-resistant subline of leukemia L1210 after discontinuation of treatment.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Chem Biol Interact; 1970 Oct; 2(3):229-34. PubMed ID: 5289825
    [No Abstract]   [Full Text] [Related]  

  • 30. Analogues of folate antagonists as affinity and fluorescent probes of dihydrofolate reductase structure and function.
    Freisheim JH; Price EM; Kumar AA; Susten SS; Smith PL; Delcamp TJ
    Biochem Soc Trans; 1986 Apr; 14(2):371-3. PubMed ID: 3086153
    [No Abstract]   [Full Text] [Related]  

  • 31. Transient inhibition of DNA synthesis by 5-fluorodeoxyuridine leads to overexpression of dihydrofolate reductase with increased frequency of methotrexate resistance.
    Schuetz JD; Gorse KM; Goldman ID; Westin EH
    J Biol Chem; 1988 Jun; 263(16):7708-12. PubMed ID: 2967290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate resistance in al L1210 cell line resulting from increased dihydrofolate reductase, decreased thymidylate synthetase activity, and normal membrane transport. Computer simulations based on network thermodynamics.
    White JC; Goldman ID
    J Biol Chem; 1981 Jun; 256(11):5722-7. PubMed ID: 7240168
    [No Abstract]   [Full Text] [Related]  

  • 33. Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.
    Dicker AP; Waltham MC; Volkenandt M; Schweitzer BI; Otter GM; Schmid FA; Sirotnak FM; Bertino JR
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11797-801. PubMed ID: 8265628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of a fluorescent analogue of folic acid.
    McAlinden TP; Hynes JB; Patil SA; Westerhof GR; Jansen G; Schornagel JH; Kerwar SS; Freisheim JH
    Biochemistry; 1991 Jun; 30(23):5674-81. PubMed ID: 1904273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate analogues. 14. Synthesis of new gamma-substituted derivatives as dihydrofolate reductase inhibitors and potential anticancer agents.
    Rosowsky A; Forsch R; Uren J; Wick M
    J Med Chem; 1981 Dec; 24(12):1450-5. PubMed ID: 6796689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate and extent of interconversion of tetrahydrofolate cofactors to dihydrofolate after cessation of dihydrofolate reductase activity in stationary versus log phase L1210 leukemia cells.
    Trent DF; Seither RL; Goldman ID
    J Biol Chem; 1991 Mar; 266(9):5445-9. PubMed ID: 1825999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of dihydrofolate reductase in individual parental and methotrexate-resistant murine cells. Use of a fluorescence activated cell sorter.
    Kaufman RJ; Bertino JR; Schimke RT
    J Biol Chem; 1978 Aug; 253(16):5852-60. PubMed ID: 670236
    [No Abstract]   [Full Text] [Related]  

  • 38. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
    Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects.
    Spinella MJ; Brigle KE; Freemantle SJ; Sierra EE; Goldman ID
    Biochem Pharmacol; 1996 Sep; 52(5):703-12. PubMed ID: 8765468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.